MMIRF vs REGN: Which Stock is Better?

Side-by-side comparison of MedMira Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MMIRF

MedMira Inc

$0.01

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricMMIRFREGNWinner
Market Cap$9.64M$77.69BREGN
P/E RatioN/A17.57REGN
EPS (TTM)$N/A$41.71REGN
Revenue Growth-0.1%0.0%REGN
Gross Margin-271.6%45.8%REGN

Analyze MMIRF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MMIRF or REGN a better investment?

Comparing MMIRF and REGN: MedMira Inc has a market cap of $9.64M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MMIRF and REGN?

MMIRF (MedMira Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MMIRF or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MMIRF or REGN?

REGN has higher revenue growth at 0.0% vs -0.1% for MMIRF.

Which company is more profitable: MMIRF or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -271.6% for MMIRF.

Which is the larger company: MMIRF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $9.64M for MMIRF.

Should I buy MMIRF or REGN in 2026?

Both MMIRF and REGN have investment merit. MMIRF trades at $0.01 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MMIRF and REGN stock?

Key differences: Market Cap ($9.64M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-271.6% vs 45.8%).

Popular Stock Comparisons